Compounds > efavirenz

efavirenz and Lipodystrophy

efavirenz has been researched along with Lipodystrophy in 23 studies

Research

Studies (23)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (17.39)18.2507
2000's13 (56.52)29.6817
2010's6 (26.09)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amogne, W; Assefa, G; Caulk, AW; Getenet, H; Gleason, RL; Parker, I; Seifu, D; Vidakovic, B1
Cai, W; Caughey, B; Chung, C; Dai, Z; Hu, F; Lan, Y; Li, L; Tang, X; Zhang, K1
Bednasz, C; DiFrancesco, R; Feng, Z; Fischl, MA; Gripshover, BM; Gu, J; Luque, AE; Ma, Q; Morse, GD; Venuto, CS; Zingman, BS1
Birbal, S; Dheda, M; Ojewole, E; Oosthuizen, F1
Naidoo, P; Soorju, V1
Maggiolo, F1
Bani-Sadr, F; Carrieri, P; Dabis, F; Lacombe, K; Loko, MA; Morlat, P; Neau, D; Salmon, D; Serfaty, L; Winnock, M1
Leen, CL1
Crespo, M; Ferrer, E; Fisac, C; Fumero, E; Gatell, JM; Podzamczer, D; Ribera, E; Roson, B; Virgili, N1
Aurpibul, L; Lee, B; Mangklabruks, A; Puthanakit, T; Sirisanthana, T; Sirisanthana, V1
Gatell, JM; Martínez, E1
Moyle, G1
Baldwin, C; Moyle, G1
Bianchi, L; Blanco, JL; Buira, E; Casamitjana, R; Conget, I; García-Viejo, MA; Gatell, JM; Mallolas, J; Martínez, E1
Bricaire, F; Dominguez, S1
Faure, I; Leng, B; Mercié, P; Pellegrin, JL; Rispal, P; Thiébaut, R; Viallard, JF1
Hanna, L1
Fornataro, K1
Bickel, M; Jacobi, V; Rickerts, V; Staszewski, S; Tews, J1

Reviews

3 review(s) available for efavirenz and Lipodystrophy

ArticleYear
Efavirenz: a decade of clinical experience in the treatment of HIV.
    The Journal of antimicrobial chemotherapy, 2009, Volume: 64, Issue:5

    Topics: Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Drug Resistance, Viral; HIV Infections; Humans; Lipodystrophy; Randomized Controlled Trials as Topic; Treatment Outcome

2009
Perspectives on HAART: switch maintenance therapy.
    International journal of STD & AIDS, 2003, Volume: 14, Issue:9

    Topics: Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Dideoxynucleosides; HIV Infections; HIV Protease Inhibitors; Humans; Lipodystrophy; Metabolic Diseases; Nevirapine; Oxazines; Patient Compliance; Reverse Transcriptase Inhibitors

2003
Efavirenz: practicalities, considerations and new issues.
    International journal of clinical practice. Supplement, 1999, Volume: 103

    Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclopropanes; Humans; Lipodystrophy; Nervous System Diseases; Oxazines; Reverse Transcriptase Inhibitors

1999

Trials

2 trial(s) available for efavirenz and Lipodystrophy

ArticleYear
Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine.
    AIDS (London, England), 2005, Jun-10, Volume: 19, Issue:9

    Topics: Adult; Alkynes; Anthropometry; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Blood Glucose; Cholesterol; Cholesterol, HDL; Cyclopropanes; Dideoxynucleosides; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Insulin Resistance; Lipodystrophy; Male; Middle Aged; Nevirapine; Oxazines; Reverse Transcriptase Inhibitors; Triglycerides

2005
Impact of switching from human immunodeficiency virus type 1 protease inhibitors to efavirenz in successfully treated adults with lipodystrophy.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2000, Volume: 31, Issue:5

    Topics: Adipose Tissue; Adult; Alkynes; Benzoxazines; Blood Glucose; Body Constitution; Body Mass Index; Cyclopropanes; Female; HIV Infections; HIV-1; Humans; Lipids; Lipodystrophy; Male; Middle Aged; Oxazines; Protease Inhibitors; Reverse Transcriptase Inhibitors; RNA, Viral; Time Factors; Treatment Outcome; Viral Load

2000

Other Studies

18 other study(ies) available for efavirenz and Lipodystrophy

ArticleYear
Current Efavirenz (EFV) or ritonavir-boosted lopinavir (LPV/r) use correlates with elevate markers of atherosclerosis in HIV-infected subjects in Addis Ababa, Ethiopia.
    PloS one, 2015, Volume: 10, Issue:4

    Topics: Adult; Alkynes; Anti-HIV Agents; Atherosclerosis; Benzoxazines; Biomarkers; Blood Pressure; C-Reactive Protein; Carotid Intima-Media Thickness; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Cyclopropanes; Ethiopia; Female; Heart Rate; HIV Infections; HIV-1; Humans; Lipodystrophy; Lopinavir; Male; Middle Aged; Nevirapine; Pulse Wave Analysis; Ritonavir; Triglycerides

2015
Plasma Mitochondrial DNA Levels as a Biomarker of Lipodystrophy Among HIV-infected Patients Treated with Highly Active Antiretroviral Therapy (HAART).
    Current molecular medicine, 2015, Volume: 15, Issue:10

    Topics: Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Biomarkers; Case-Control Studies; Cyclopropanes; DNA, Mitochondrial; Drug Combinations; Female; HIV; HIV Infections; Humans; Lamivudine; Lipodystrophy; Lopinavir; Male; Middle Aged; Mitochondria; Nelfinavir; Predictive Value of Tests; Ritonavir; ROC Curve; Stavudine; Zidovudine

2015
Lipid-Lowering Therapy in HIV-Infected Patients: Relationship with Antiretroviral Agents and Impact of Substance-Related Disorders.
    Current vascular pharmacology, 2016, Volume: 14, Issue:3

    Topics: Adult; Alkynes; Anti-Retroviral Agents; Benzoxazines; Cyclopropanes; Dyslipidemias; Female; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertriglyceridemia; Hypolipidemic Agents; Lipids; Lipodystrophy; Male; Middle Aged; Retrospective Studies; Substance-Related Disorders

2016
Adverse drug reactions associated with antiretroviral therapy in South Africa.
    African journal of AIDS research : AJAR, 2016, Volume: 15, Issue:3

    Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Dizziness; Exanthema; Female; Gynecomastia; HIV Infections; Humans; Lipodystrophy; Male; Middle Aged; Nevirapine; Peripheral Nervous System Diseases; Renal Insufficiency; Retrospective Studies; South Africa; Stavudine; Tenofovir; Zidovudine

2016
Confirmation of factors that influence antiretroviral regimen change and the subsequent patient outcomes at a Regional Hospital in rural KwaZulu-Natal.
    African journal of primary health care & family medicine, 2016, Oct-31, Volume: 8, Issue:1

    Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Female; HIV Infections; Hospitals; Humans; Lamivudine; Lipodystrophy; Male; Middle Aged; Retrospective Studies; Rural Population; South Africa; Stavudine; Tenofovir; Treatment Outcome; Tuberculosis; Viral Load; Young Adult

2016
Impact of HAART exposure and associated lipodystrophy on advanced liver fibrosis in HIV/HCV-coinfected patients.
    Journal of viral hepatitis, 2011, Volume: 18, Issue:7

    Topics: Adult; Alkynes; Antiretroviral Therapy, Highly Active; Antiviral Agents; Benzoxazines; CD4 Lymphocyte Count; Coinfection; Cyclopropanes; Didanosine; Female; Hepatitis C; HIV Infections; Humans; Insulin Resistance; Lipodystrophy; Liver Cirrhosis; Male; Middle Aged; Mitochondria; Sex Factors; Stavudine

2011
Anti-HIV agents. New drugs, new hope, old lessons.
    TreatmentUpdate, 2007, Volume: 19, Issue:2

    Topics: Alkynes; Anti-HIV Agents; Benzoxazines; CCR5 Receptor Antagonists; CD4 Lymphocyte Count; Cyclohexanes; Cyclopropanes; HIV Infections; HIV Integrase Inhibitors; Humans; Lipodystrophy; Maraviroc; Organic Chemicals; Pyrrolidinones; Raltegravir Potassium; Triazoles; Viral Load

2007
Anti-HIV agents. American study finds efavirenz linked to fat wasting.
    TreatmentUpdate, 2007, Volume: 19, Issue:2

    Topics: Adult; Alkynes; Benzoxazines; CD4 Lymphocyte Count; Cholesterol; Cyclopropanes; Female; Humans; Lipodystrophy; Male; Reverse Transcriptase Inhibitors; Viral Load

2007
Anti-HIV agents. A second study confirms fat loss issues with efavirenz.
    TreatmentUpdate, 2007, Volume: 19, Issue:2

    Topics: Adult; Alkynes; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Lipodystrophy; Male; Reverse Transcriptase Inhibitors; Viral Load

2007
Anti-HIV agents. Efavirenz and fat wasting--what might be happening?
    TreatmentUpdate, 2007, Volume: 19, Issue:2

    Topics: Alkynes; Benzoxazines; Cyclopropanes; HIV Infections; Humans; Lipodystrophy; Reverse Transcriptase Inhibitors

2007
Lipodystrophy and metabolic changes in HIV-infected children on non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.
    Antiviral therapy, 2007, Volume: 12, Issue:8

    Topics: Adolescent; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Child; Child, Preschool; Cyclopropanes; Female; HIV Infections; HIV-1; Humans; Hypercholesterolemia; Hyperglycemia; Hypertriglyceridemia; Lamivudine; Lipodystrophy; Male; Nevirapine; Prevalence; Reverse Transcriptase Inhibitors; Stavudine; Thailand

2007
[Lipodystrophy and antiretroviral agents].
    Revista clinica espanola, 1999, Volume: 199, Issue:8

    Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; HIV Protease Inhibitors; HIV-1; Humans; Hyperlipidemias; Lipodystrophy; Nevirapine; Oxazines; Reverse Transcriptase Inhibitors; Syndrome

1999
Switching from a PI-based to a PI-sparing regimen for management of metabolic or clinical fat redistribution.
    The AIDS reader, 2000, Volume: 10, Issue:8

    Topics: Acquired Immunodeficiency Syndrome; Adipose Tissue; Alkynes; Benzoxazines; Cyclopropanes; Dideoxynucleosides; HIV Protease Inhibitors; Humans; Lipodystrophy; Nevirapine; Oxazines

2000
[Antiretroviral therapies].
    Presse medicale (Paris, France : 1983), 2000, Dec-02, Volume: 29, Issue:37

    Topics: Adenine; Alkynes; Antiviral Agents; Benzoxazines; Cyclopropanes; Dioxolanes; Humans; Lipodystrophy; Organophosphonates; Organophosphorus Compounds; Oxazines; Patient Compliance; Protease Inhibitors; Purine Nucleosides; Reverse Transcriptase Inhibitors; Tenofovir; Viral Load

2000
Efavirenz-associated breast hypertrophy in HIV-infection patients.
    AIDS (London, England), 2001, Jan-05, Volume: 15, Issue:1

    Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Breast Diseases; Cyclopropanes; HIV Infections; Humans; Lipodystrophy; Male; Middle Aged; Oxazines; Reverse Transcriptase Inhibitors

2001
A new approach to initial antiretroviral therapy: protease-sparing combination regimens.
    BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation, 1998

    Topics: Alkynes; Anti-HIV Agents; Antineoplastic Agents; Benzoxazines; Clinical Trials as Topic; Cyclopropanes; Dideoxynucleosides; Drug Resistance, Microbial; Drug Therapy, Combination; Drugs, Investigational; HIV Infections; HIV Protease Inhibitors; Humans; Hydroxyurea; Lamivudine; Lipodystrophy; Oxazines; Reverse Transcriptase Inhibitors; Time Factors; Zidovudine

1998
Switching drugs for lipodystophy.
    The Body positive, 1999, Volume: 12, Issue:5

    Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cholesterol; Cyclopropanes; Drug Administration Schedule; HIV Infections; Humans; Lipodystrophy; Nevirapine; Oxazines; Reverse Transcriptase Inhibitors; Triglycerides

1999
A case of lipodystrophy after the initiation of zidovudine, lamivudine and efavirenz in an asymptomatic HIV-1-infected patient.
    HIV medicine, 2000, Volume: 1, Issue:3

    Topics: Abdomen; Adipose Tissue; Adult; Alkynes; Benzoxazines; Cyclopropanes; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Lamivudine; Lipodystrophy; Male; Oxazines; Reverse Transcriptase Inhibitors; Tomography, X-Ray Computed; Zidovudine

2000